Literature DB >> 20915

A spectrofluorometric method for the determination of ajmaline in plasma.

E Welman, P V Curry, D M Krikler, E Rowlands, E A Callowhill.   

Abstract

1 Ajmaline was found to have maximum fluorescence at neutral pH with 300 nm excitation and 365 nm emission wavelengths (corrected). 2 The fluorescence intensity had a linear relationship to concentration up to 50 microgram ml-1 and the recovery of ajmaline after extraction from plasma was 92.5 +/- 3%. 3 Extraction of drug-free plasma and of samples containing known concentrations of ajmaline showed that drug levels in the range found clinically could be measured accurately by fluorimetry. 4 Serial plasma ajmaline concentrations were measured in a subject after intravenous injection of ajmaline (50 mg). The rates of plasma clearance of the drug were found to be similar to those obtained in previous studies.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 20915      PMCID: PMC1429148          DOI: 10.1111/j.1365-2125.1977.tb00784.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  Determination of 17-monochloroacetylajmaline and its metabolite in plasma by TLC fluorescence detection.

Authors:  L J Dombrowski; A V Crain; R S Browning; E L Pratt
Journal:  J Pharm Sci       Date:  1975-04       Impact factor: 3.534

2.  Cardiovascular effects and blood concentrations of ajmaline and its 17-monochloroacetate ester in cats.

Authors:  B Spilker; L Shargel; R F Koss; H Minatoya
Journal:  Arch Int Pharmacodyn Ther       Date:  1975-07

3.  [A POLAROGRAPHIC METHOD OF DETERMINATION OF AJMALIN. I].

Authors:  N Ia TSARENKO; Iu E ORLOV; M S SHRAIBER
Journal:  Med Prom SSSR       Date:  1963-09

4.  Antiarrhythmics. VI. Ajmaline and serpentine in experimental cardiac arrhythmias.

Authors:  R B ARORA; B R MADAN
Journal:  J Pharmacol Exp Ther       Date:  1956-05       Impact factor: 4.030

Review 5.  Cardiac pharmacology.

Authors:  R Mendez; E Kabela
Journal:  Annu Rev Pharmacol       Date:  1970       Impact factor: 13.820

6.  [Determination of ajmaline in dosage forms].

Authors:  M Sobiczewska; B Borkowski
Journal:  Pharmazie       Date:  1970 May-Jun       Impact factor: 1.267

7.  [Identification reactions of ajmaline].

Authors:  O N Yalcindağ; E E Onur
Journal:  Turk Hij Tecr Biyol Derg       Date:  1969

8.  [Action of ajmaline in the Wolff-Parkinson-White syndrome. Diagnostic value].

Authors:  J Soler Soler; A Casellas Bernat; E Trilla Sánchez
Journal:  Arch Inst Cardiol Mex       Date:  1966 Jan-Feb
  8 in total
  1 in total

1.  Ajmaline test in a patient with chronic renal failure. A pharmacokinetic and pharmacodynamic study.

Authors:  R Padrini; L Compostella; D Piovan; A Javarnaro; F Cucchini; M Ferrari
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.